Chronic pulmonary diseases encompass different persistent and lethal diseases, including
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …

The emergence of novel respiratory infections (eg, COVID-19) and expeditious development
of nanoparticle-based COVID-19 vaccines have recently reignited considerable interest in …

Simple Summary As lung cancer has the highest incidence rate compared to any other type
of cancer, there have been extensive research studies aiming at finding a better treatment …

Numerous long noncoding RNAs (lncRNAs) have been identified as powerful regulators of
human diseases. The lncRNA FOXD3-AS1 is a novel lncRNA that was recently shown to …

Given the unique physiological and pathological characteristics of the lung, the direct,
inhalable route is more conducive to pulmonary drug delivery and disease control than …

Background The blood-brain barrier (BBB) is a complex and dynamic structure that serves
as a gatekeeper, restricting the migrations of most compounds and molecules from blood …

Purpose Cancer cells maintain cell growth, division, and survival through altered energy
metabolism. However, research on metabolic reprogramming in lung adenocarcinoma …

Abstract Poly (ethylene glycol)-poly (n-butyl cyanoacrylate)(PEG-PBCA) is a remarkable
drug delivery carrier for permeating blood-brain barrier. In this work, a novel high-gravity …

The introduction of nanotechnology in the pharmaceutical field has incited the attention of
researchers to develop nanoparticle-based formulations to treat pulmonary diseases. The …

The present review describes all the aspect of pulmonary drug delivery system and recent
advancement. It deals with the delivery of drugs in important disease conditions like asthma …